References
- 1. Anderlová K. et. al.: The influence of very-low-calorie-diet on serum leptin, soluble leptin receptor, adiponectin and resistin levels in obese women. Physiol. Res., 55(3), 277, 2006.
- 2. Bays H.E.: Adiposopathy is “sick fat” a cardiovascular disease? J. Am. Coll. Cardiol., 57(25), 2461, 2011.
- 3. Blüher M., Mantzoros C.S.: From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century. Metabolism, 64(1), 131, 2015.
- 4. Chen G.C., Qin L.Q., Ye J.K.: Leptin levels and risk of type 2 diabetes: gender-specific meta-analysis. Obes. Rev., 15(2), 134, 2014.
- 5. Chen K. et. al.: Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat. Med., 12(4), 425, 2006.
- 6. Correia M.L., Rahmouni K.: Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome. Diabetes Obes. Metab., 8(6), 603, 2006.
- 7. Dardeno T.A. et. al.: Leptin in human physiology and therapeutics. Front Neuroendocrinol., 31(3), 377, 2010.
- 8. Denroche H.C., Huynh F.K., Kieffer T.J.: The role of leptin in glucose homeostasis. J. Diabetes Investig., 3(2), 115, 2012.
- 9. Esteghamati A. et. al.: Association of serum leptin levels with homeostasis model assessment-estimated insulin resistance and metabolic syndrome: the key role of central obesity. Metab. Syndr. Relat. Disord. 7(5), 447, 2009.
- 10. Esteghamati A. et. al.: Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistant and obesity. Diabetes Res. Clin. Pract., 91(2), 154, 2011.
- 11. Friedewald W.T., Levy R.I., Fredrickson D.S.: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem., 18(6), 499, 1972.
- 12. Gui Y., Silha J.V., Murphy L.J.: Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse. Obes. Res., 12(9), 1481, 2004.
- 13. Kershaw E.E., Flier J.S.: Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab,. 89(6), 2548, 2004.
- 14. Lee J.M. et. al.: The relationship between adipokines, metabolic parameters and insulin resistance in patients with metabolic syndrome and type 2 diabetes. Int. Med. Res., 37(6), 1803, 2009.
- 15. Levey A.S. et. al.: Using standardized serum creatinine values in the modification of diet in the renal disease study equation for estimating glomerular filtration rate. Ann. Intern. Med., 145(4), 247, 2006.
- 16. Ley S.H. et. al.: Adipokines and incident type 2 diabetes in an Aboriginal Canadian population: the Sandy Lake Health and Diabetes Project. Diabetes Care, 31(7), 1410, 2008.
- 17. Malecha-Jedraszek A. et. al.: Concentration of adiponectin in relation to insulin resistance in patients with type 2 diabetes. Ann. UMCS Sect. DDD, 24 (4), 73, 2011.
- 18. Martos-Moreno G.Á. et. al.: Effect of weight loss on high-molecular weight adiponectin in obese children. Obesity (Silver Spring),18(12), 2288, 2010.
- 19. Matthews D.R. et. al.: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7), 412, 1985.
- 20. Menon V. et. al.: Factors associated with serum leptin in patients with chronic kidney disease. Clin. Nephrol., 61(3), 163, 2004.
- 21. Olstad R. et. al.: Leptin in the General Population, Differences in Sex Hormones, Blood Lipids, Gender and Life Style Characteristics. The Open Behavioral Science Journal, 5, 8, 2011.
- 22. Park H.K., Ahima R.S.: Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism, 64(1), 24, 2015.
- 23. Paz-Filho G. et. al.: Leptin: molecular mechanisms, systemic proinflammatory effects, and clinical implications. Arq. Bras. Endocrinol. Metabol., 56(9), 597, 2012.
- 24. Saginova E.A. et. al.: The role of leptin, adiponectin and insulinresistance markers in development of early stages of chronic kidney disease and atherosclerosis of carotid arteries in obese patients. Ter. Arkh., 83(6), 47, 2011.
- 25. Sáinz N. et. al.: Leptin resistance and diet-induced obesity: central and peripheral actions of leptin. Metabolism, 64(1), 35, 2015.
- 26. Silha J.V. et. al.: Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur. J. Endocrinol., 149(4), 331, 2003.
- 27. Söderberg S. et. al.: Leptin predicts the development of diabetes in Mauritian men, but not women: a population-based study. Int. J. Obes. (Lond)., 31(7), 1126, 2007.
- 28. Sun Q. et. al.: Leptin and soluble leptin receptor levels in plasma and risk of type 2 diabetes in U.S. women: a prospective study. Diabetes, 2010; 611, 59(3).
- 29. Tokuyama Y. et. al.: Serum resistin level is associated with insulin sensitivity in Japanese patients with type 2 diabetes mellitus. Metabolism, 56(5), 693, 2007.
- 30. Wang H., Luo W., Eitzman D.T.: Leptin in thrombosis and atherosclerosis. Curr. Pharm. Des., 20(4), 641, 2014.
- 31. Wannamethee S.G. et. al.: Adipokines and risk of type 2 diabetes in older men. Diabetes Care, 30(5), 1200, 2007.
- 32. Wannamethee S.G. et. al.: Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis, 191(2), 18, 2007.
- 33. Welsh P. et. al.: Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population. Diabetes Care, 32(2), 308, 2009.
- 34. Wolf G., Ziyadeh F.N.: Leptin and renal fibrosis. Contrib. Nephrol., 151, 175, 2006.
- 35. World Health Organisation: Obesity: preventing and managing the global epidemic. Report of a WHO consultation, Genewa 1997.
- 36. Zhou Y., Rui L.: Leptin signaling and leptin resistance. Front Med., 7(2), 207, 2013.
- 37. Zimmet P., Alberti K.G., Serrano Ríos M.: A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results. Rev. Esp. Cardiol., 58(12), 1371, 2005.
- 38. Zuo H. et. al.: Association between serum leptin concentrations and insulin resistance: a population-based study from China. PLoS One, 8(1), 1, 2013.